Clinical trial
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple…
NCT03085888 · GRAIL, Inc., Industry · Completed
Key facts
| NCT number | NCT03085888 |
|---|---|
| Title | The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types |
| Official title | The STRIVE Study: Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection |
| Lead sponsor | GRAIL, Inc., Industry |
| Status | Completed |
| Study type | Observational [Patient Registry] |
| Conditions | Neoplasms, Cancer |
| Enrollment | 99,481 |
| Start date | Feb 28, 2017 |
| Primary completion | Jun 30, 2022 |
| Completion | Apr 1, 2024 |
| First posted | Mar 21, 2017 |
| Last update posted | Sep 20, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: